KALVISTA PHARMACEUTICALS INC's ticker is KALV and the CUSIP is 483497103. A total of 92 filers reported holding KALVISTA PHARMACEUTICALS INC in Q4 2022. The put-call ratio across all filers is 0.09 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $183 | -37.5% | 18,961 | -41.7% | 0.00% | – |
| Q2 2023 | $293 | +0.7% | 32,516 | -12.0% | 0.00% | – |
| Q1 2023 | $291 | +16.9% | 36,971 | +0.2% | 0.00% | – |
| Q4 2022 | $249 | -99.9% | 36,879 | +36.9% | 0.00% | – |
| Q3 2022 | $391,000 | +88.9% | 26,946 | +28.3% | 0.00% | – |
| Q2 2022 | $207,000 | -23.3% | 20,999 | +14.6% | 0.00% | – |
| Q1 2022 | $270,000 | +39.2% | 18,327 | +25.0% | 0.00% | – |
| Q4 2021 | $194,000 | – | 14,661 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SV Health Investors, LLC | 1,719,576 | $38,088,000 | 25.57% |
| VHCP Management III, LLC | 637,884 | $14,129,000 | 6.60% |
| Vivo Capital, LLC | 1,359,149 | $30,105,000 | 2.82% |
| INTERWEST VENTURE MANAGEMENT CO | 388,766 | $8,611,000 | 2.78% |
| VHCP Management II, LLC | 376,889 | $8,348,000 | 2.63% |
| Samsara BioCapital, LLC | 118,500 | $2,625,000 | 1.73% |
| ACUTA CAPITAL PARTNERS, LLC | 213,000 | $4,718,000 | 1.68% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 187,599 | $4,165,000 | 1.54% |
| Ghost Tree Capital, LLC | 300,000 | $6,645,000 | 1.38% |
| Eventide Asset Management | 1,500,000 | $33,225,000 | 1.01% |